Helen I. Torley
2020
Compensation breakdown
| Non-Equity Incentive Plan | $712,270 |
|---|---|
| Option Awards | $2,500,001 |
| Salary | $791,440 |
| Stock Awards | $2,500,018 |
| Other | $15,147 |
| Total | $6,518,876 |
Torley received $2.5M in stock awards, accounting for 38% of the total pay in 2020.
Torley also received $712.3K in non-equity incentive plan, $2.5M in option awards, $791.4K in salary and $15.1K in other compensation.
Rankings
In 2020, Helen I. Torley's compensation ranked 1,541st out of 13,090 executives tracked by ExecPay. In other words, Torley earned more than 88.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,541 out of 13,090 | 88th |
Division Manufacturing | 575 out of 5,620 | 90th |
Major group Chemicals And Allied Products | 209 out of 2,253 | 91st |
Industry group Drugs | 175 out of 1,953 | 91st |
Industry Biological Products, Except Diagnostic Substances | 54 out of 411 | 87th |
Pay ratio
| Helen I. Torley's Pay | $6,518,876 |
|---|---|
| Median Employee's Pay | $223,441 |
| Pay Ratio | 29to 1 |
In 2020, the annual total compensation of Helen I. Torley was $6,518,876.
The annual total compensation of the median employee at Halozyme Therapeutics was $223,441.
The ratio of Helen I. Torley's pay to the pay of median employee was therefore 29 to one.
Torley's colleagues
We found four more compensation records of executives who worked with Helen I. Torley at Halozyme Therapeutics in 2020.
News
March 25, 2022
March 26, 2021
March 20, 2020
March 22, 2019